Emcure Pharma Announces 45th AGM on Sep 21, 2026; Annual Report FY26 Released
Emcure Pharmaceuticals Limited will hold its 45th AGM on September 21, 2026, via VC/OAVM. The Annual Report for FY 2025-26 is released. Remote e-voting is open from September 18-20, 2026. FY26 highlights include ₹92,035 million revenue and ₹9,413 million PAT.
The announcement concerns a scheduled AGM and the release of the annual report, which are standard corporate procedures and do not introduce new material information that would significantly impact the company's stock.
The announcement is a routine corporate event (AGM) and release of the annual report, with no significant positive or negative financial news impacting the sentiment.
Emcure Pharmaceuticals Limited has announced its 45th Annual General Meeting (AGM) will be held on Monday, September 21, 2026, at 11:00 a.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in accordance with circulars from the Ministry of Corporate Affairs and SEBI.
Members holding shares as of the cut-off date, Monday, September 14, 2026, will be eligible to attend the AGM. The company has also released its Annual Report for the Financial Year 2025-26, which includes the AGM notice. Both documents are available on the company's website and the MUFG Intime India Private Limited platform.
Furthermore, the company has detailed the timeline for remote e-voting, which will commence on Friday, September 18, 2026, at 9:00 a.m. IST, and conclude on Sunday, September 20, 2026, at 5:00 p.m. IST. The Annual Report covers various aspects of the company's performance, strategy, and financial statements for FY 2025-26, including financial highlights such as revenue from operations of ₹92,035 million (up 16.6% Y-o-Y) and PAT of ₹9,413 million (up 33.1% Y-o-Y).
A plain-language summary of a public exchange filing by Emcure Pharmaceuticals Limited. Read the original for the full detail.